본문

  1. Home
3 Results:AA:YAMADA S PP:ELSEVIER INC AA:MORI, H. 0.62 sec.
RSS 
Multilingual
 高级搜索
 新货搜索
选定的打印 Select Export to Excel
1
Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia
Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia
Tanaka, M., | Elsevier Inc | 2008 ,
2
Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys
Minodronic acid (ONO-5920/YM529) prevents decrease in bone mineral density and bone strength, and improves bone microarchitecture in ovariectomized cynomolgus monkeys
Mori, H., | Elsevier Inc | 2008 ,
3
Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
Ochi, Y, | Elsevier Inc | 2011 ,
처음1마지막